The Accuracy of the CGMS™ in Children with Type 1 Diabetes: Results of the Diabetes Research in Children Network (DirecNet) Accuracy Study

Diabetes Technology and Therapeutics

Volumn 5, Issue 5, 2003, Pages 781-789

  Buckingham, Bruce A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PRIORITY JOURNAL; REFERENCE VALUE; RELIABILITY; SENSOR; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; HEALTH CARE ORGANIZATION; INSTRUMENTATION; METHODOLOGY; MONITORING; PRESCHOOL CHILD; QUALITY CONTROL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD;

ADOLESCENT; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; MONITORING, PHYSIOLOGIC; QUALITY CONTROL; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOCIETIES;

EID: 0242268979     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/152091503322526987     Document Type: Article

References (14)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 1993;329:977-986.
2. Mortensen H, Hougaard P, for the Hvidore Study Group on Childhood Diabetes: Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. Diabetes Care 1997;20:714-720.
3. Diabetes Control and Complications Trial Research Group: Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994;125:228-229.
4. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV: Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001;24:1858-1862.
5. Amin R, Ross K, Acerini C, Edge J, Warner J, Dunger D: Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of Continuous Glucose Monitoring System. Diabetes Care 2003;26:662-667.
6. Kaufman FR, Austin J, Neinstein A, Jeng L, Halvorson M, Devoe DJ, Pitukcheewanont P: Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes. J Pediatr 2002;141:625-630.
7. McGowan K, Thomas W, Moran A: Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 2002;25:1499-1503.
8. Metzger M, Leibowitz G, Wainstein J, Glaser B, Raz I: Reproducibility of glucose measurements using the glucose sensor. Diabetes Care 2002;25:1185-1191.
9. Diabetes Research in Children Network (DirecNet) Study Group: The accuracy of the GlucoWatch® G2™ Biographer in children with type 1 diabetes: results of the Diabetes Research in Children Network (DirecNet) accuracy study. Diabetes Technol Ther 2003;5:791-800.
10. Skeie S, Thue G, Nerhus K, Sandberg S: Instruments for self-monitoring of blood glucose: comparisons of testing quality achieved by patients and a technician. Clin Chem 2002;48:994-1003
11. Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH, Mastrototaro JJ: Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2000;2:49-56.
12. Gross TM, Mastrototaro JJ: Efficacy and reliability of the Continuous Glucose Monitoring System. Diabetes Technol Ther 2000;2(Suppl 1):S19-S26.
13. Gross TM, Ter Veer A: Continuous glucose monitoring in previously unstudied population subgroups. Diabetes Technol Ther 2000;2(Suppl 1):S27-S34.
14. Guerci B, Floriot M, Bohme P, Durain D, Benichou M, Jellimann S, Drouin P: Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. Diabetes Care 2003;26:582-589.